Related Experiment Video
Updated: Jul 29, 2026

08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats.
I Castagliuolo1, K Karalis, L Valenick
1Division of Gastroenterology, Beth Israel Deaconess Medical Center, Massachusetts, Boston 02215, USA.
Summary
Clostridium difficile toxin A triggers endogenous glucocorticoids, which then reduce the toxin's inflammatory and secretory effects in the gut. This study reveals a protective feedback loop in toxin A-induced diarrhea.
Area of Science:
- Gastroenterology
- Immunology
- Endocrinology
Background:
- Clostridium difficile toxin A is a key mediator of acute inflammatory diarrhea.
- The role of endogenous glucocorticoids in modulating toxin A-induced intestinal responses remains unclear.
Purpose of the Study:
- To investigate the involvement of glucocorticoids in Clostridium difficile toxin A-mediated acute inflammatory diarrhea.
- To elucidate the regulatory mechanisms of glucocorticoids on intestinal secretion and inflammation induced by toxin A.
Main Methods:
- Administration of Clostridium difficile toxin A or buffer into rat ileal loops.
- Measurement of intestinal responses, plasma glucocorticoid levels, and macrophage inflammatory protein-2.
- Experimental manipulation using dexamethasone (glucocorticoid analog), adrenalectomy with glucocorticoid replacement, and RU-486 (glucocorticoid receptor antagonist).
Main Results:
- Ileal toxin A administration led to increased plasma glucocorticoids.
- Dexamethasone significantly inhibited toxin A-induced intestinal secretion and inflammation.
- RU-486 administration enhanced toxin A-mediated intestinal secretion and inflammation, indicating a protective role for glucocorticoids.
Conclusions:
- Clostridium difficile toxin A induces the secretion of endogenous glucocorticoids.
- These endogenous glucocorticoids act to diminish the intestinal secretory and inflammatory effects of toxin A, suggesting a negative feedback mechanism.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

